| Literature DB >> 22560076 |
Maria Carolina Florian1, Karin Dörr, Anja Niebel, Deidre Daria, Hubert Schrezenmeier, Markus Rojewski, Marie-Dominique Filippi, Anja Hasenberg, Matthias Gunzer, Karin Scharffetter-Kochanek, Yi Zheng, Hartmut Geiger.
Abstract
The decline in hematopoietic function seen during aging involves a progressive reduction in the immune response and an increased incidence of myeloid malignancy, and has been linked to aging of hematopoietic stem cells (HSCs). The molecular mechanisms underlying HSC aging remain unclear. Here we demonstrate that elevated activity of the small RhoGTPase Cdc42 in aged HSCs is causally linked to HSC aging and correlates with a loss of polarity in aged HSCs. Pharmacological inhibition of Cdc42 activity functionally rejuvenates aged HSCs, increases the percentage of polarized cells in an aged HSC population, and restores the level and spatial distribution of histone H4 lysine 16 acetylation to a status similar to that seen in young HSCs. Our data therefore suggest a mechanistic role for Cdc42 activity in HSC biology and epigenetic regulation, and identify Cdc42 activity as a pharmacological target for ameliorating stem cell aging.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22560076 PMCID： PMC3348626 DOI： 10.1016/j.stem.2012.04.007
Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633